Company Monitoring Page for Roche

latest headlines for company on cafepharma

Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
Tags:
bladder cancer, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, Roche, Tecentriq, AstraZeneca, durvalumab
2 Big Reasons Exelixis, Inc. Soared 22% in January
Motley Fool
Thu, 02/2/17 - 09:17 am
Tags:
Exelixis, Cotellic, Roche, cabozantinib, Takeda
Roche: What To Expect At FY 2016 Results
Seeking Alpha
Mon, 01/30/17 - 11:46 am
Tags:
Roche, earnings
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:36 pm
Tags:
Merck, Sanofi, Eli Lilly, Pfizer, Roche, AstraZeneca, Gilead Sciences, Allergan, GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Tags:
Bristol-Myers Squibb, Merck, Roche, Gilead Sciences
Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Tags:
Roche, Bristol-Myers Squibb, Tecentriq, non-small cell lung cancer, Opdivo
Did Roche Just Hand Illumina Pacific Biosciences’ Head on a Platter?
Motley Fool
Thu, 01/19/17 - 11:34 pm
Tags:
Roche, Illumina, Pacific Biosciences, diagnostics
Roche’s Multiple Sclerosis Drug Shows Positive Results in Several Clinical Trials
Xtalks
Fri, 01/13/17 - 11:20 am
Tags:
Roche, MS, multiple sclerosis, ocrelizumab, clinical trials
Roche Has Aphinity For Perjeta Trial Success, But Not Puma
Seeking Alpha
Sun, 01/8/17 - 03:28 pm
Tags:
Roche, Perjeta, Puma Biotechnology, breast cancer
Roche touts efficacy of MS drug despite delays
BioPharma Dive
Tue, 12/27/16 - 10:16 am
Tags:
Roche, MS, multiple sclerosis, Ocrevus, ocrelizumab
Roche Finds Safe Haven In Emicizumab
Seeking Alpha
Sat, 12/24/16 - 12:13 pm
Tags:
Roche, emicizumab, hemophilia A
Roche readies a hunt for marketing OK on hemophilia blockbuster hopeful emicizumab after PhIII success
Endpoints
Thu, 12/22/16 - 11:40 am
Tags:
Roche, hemophilia A, ACE910, emicizumab
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Tags:
Ophthalmic Drugs Market, Ocular Therapeutix, Eylea, Restasis, Lucentis, Regeneron, Roche, Allergan
FDA pushes decision on Roche MS drug to March
BioPharma Dive
Wed, 12/21/16 - 11:13 am
Tags:
FDA, Roche, MS, multiple sclerosis, Ocrevus, ocrelizumab
Roche's Leukemia Drug Approved for Next Step in Europe
Yahoo/GuruFocus
Mon, 12/12/16 - 09:30 am
Tags:
Roche, chronic lymphocytic leukemia, Europe, venetoclax, Venclyxto
Alnylam touts hemophilia drug's edge over Roche rival
BioPharma Dive
Fri, 12/2/16 - 10:48 am
Tags:
Alnylam, Roche, hemophilia, fitusiran
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
TheStreet.com
Tue, 11/29/16 - 09:49 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab, AC Immune, Axovant, Biogen, Merck, Roche
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Motley Fool
Mon, 11/21/16 - 02:35 pm
Tags:
Alzheimer's disease, AstraZeneca, Biogen, Eli Lilly, Merck, Roche, BACE inhibitors
Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class
Market Realist
Mon, 11/21/16 - 11:39 am
Tags:
AstraZeneca, anti-PD-L1, durvalumab, Opdivo, Keytruda, Tecentriq, Bristol-Myers Squibb, Roche, Merck
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Tags:
Amgen, Allergan, Roche, Avastin, biosimilars, FDA, ABP 215

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.